PFE - Pfizer's Elrexfio buoyed by multiple myeloma survival data
2024-06-14 08:49:30 ET
More on Pfizer
- Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon
- Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Pfizer: Surging Cancer Rates Will Boost Revenues
- FDA recommends KP.2 strain be used in updated COVID-19 shots
- Sarepta gains after Pfizer's late-stage setback for Duchenne therapy